IM Cannabis Corp. (IMCC)
NASDAQ: IMCC · Real-Time Price · USD
0.3390
+0.0337 (11.04%)
At close: Apr 2, 2026, 4:00 PM EDT
0.3200
-0.0190 (-5.60%)
After-hours: Apr 2, 2026, 7:59 PM EDT
Company Description
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany.
It provides medical cannabis dried flowers; and cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands.
The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv-Yafo, Israel.
IM Cannabis Corp.
| Country | Israel |
| Founded | 1980 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 95 |
| CEO | Oren Shuster |
Contact Details
Address: Kibbutz Glil Yam, Central District Tel Aviv-Yafo, 4690500 Israel | |
| Website | imcannabis.com |
Stock Details
| Ticker Symbol | IMCC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| CIK Code | 1792030 |
| CUSIP Number | 44969Q208 |
| ISIN Number | CA44969Q4060 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Eyal Fisher | Chief Executive Officer of the IMC Holdings |
| Richard Balla | Chief Executive Officer of Adjupharm |
| Oren Shuster | Chief Executive Officer and Executive Director |
| Advocate Michal Lebovitz Nissimov | General Counsel and Secretary |
| Asi Levi | Chief Financial Officer |
| Anna Taranko | Director Investor and Public Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 31, 2026 | 6-K | Report of foreign issuer |
| Mar 30, 2026 | 20-F | Annual and transition report of foreign private issuers |
| Mar 17, 2026 | 6-K | Report of foreign issuer |
| Feb 11, 2026 | EFFECT | Notice of Effectiveness |
| Feb 5, 2026 | F-3 | Filing |
| Jan 26, 2026 | 6-K | Report of foreign issuer |
| Jan 5, 2026 | 6-K | Report of foreign issuer |
| Dec 30, 2025 | 6-K | Report of foreign issuer |
| Dec 12, 2025 | 6-K | Report of foreign issuer |
| Nov 17, 2025 | 6-K | Report of foreign issuer |